본문 바로가기 대메뉴 바로가기

진료과 검색

비뇨의학과

이상철 교수

전문분야

요로폐색, 요석, 수신증, 내비뇨, 전립선

진료일정

원모양 외래 삼각형모양 클리닉
테이블 자료 : 진료시간, 오전, 오후, 요일별 가능날짜 정보제공
오전 진료
오후 진료
비고 -
학회 및 출장등의 이유로 실제 진료스케줄과 차이가 있을 수 있습니다.
이상철 교수

충북대학교병원 X 비뇨의학과

의료진 한마디

학력 및 경력

  • 경희대학교 의과대학 의학사
  • 경희대학교 의과대학 의학석사
  • 경희대학교 의과대학 의학박사
  • 경희대학병원 비뇨기과학 전문의과정 수료
  • 전 충북대학교병원 진료처장
  • 현 충북대학교 의과대학 교수

학회활동

  • 대한비뇨기학회 정회원
논문연구실적 - 발표년도, 논문명 정보 제공
발표년도 제목
2017 Impact of the ASA Physical Status Score on AdjuvantChemotherapy Eligibility and Survival of Upper TractUrothelial Carcinoma Patients: a Multicenter Study. JOURNAL OF KOREAN MEDICAL SCIENCE 2017;32(2):335-342 2017 Genetic variation of the PSCA gene (rs2294008) is notassociated with the risk of prostate cancer. Journal of Biomedical Research 2017;31(3):226-231 2017 Garlic extract in bladder cancer prevention: Evidencefrom T24 bladder cancer cell xenograft model, tissuemicroarray, and gene network analysis. INTERNATIONAL JOURNAL OF ONCOLOGY 2017;51(1):204-212 2017 Metabolic Characteristics and Risks Associated withStone Recurrence in Korean Young Adult Stone Patients. JOURNAL OF ENDOUROLOGY 2017;31(8):806-811 2017 Long-term validation of a molecularprogression-associated gene classifier for prediction ofmuscle invasion in primary non-muscle-invasive bladdercancer. ONCOLOGY LETTERS 2017;14(2):2468-2474 2017 Chronological Trends in Clinical and Urinary MetabolicFeatures over 20 Years in Korean Urolithiasis Patients. JOURNAL OF KOREAN MEDICAL SCIENCE 2017;32(9):1496-1501 2017 한국에서 Biochemical Recurrence의 진단에 대한 혈액 및 영상의학적 검사에 관한 비뇨기종양을 전공하는 의사의 트렌드에대한 고찰. 대한비뇨기종양학술지 2017;15(3):131-136 2018 The Anticancer Effects of Garlic Extracts on BladderCancer Compared to Cisplatin: A Common Mechanismof Action via Centromere Protein M. AMERICAN JOURNAL OF CHINESEMEDICINE 2018;46(3):689-705 2018 Urinary cell-free nucleic acid IQGAP3: A newnon-invasive diagnostic marker for bladder cancer. Oncotarget 2018;9(18):14354-14365 2018 Urinary cell-free nucleic acid IQGAP3: A newnon-invasive diagnostic marker for bladder cancer. Oncotarget 2018;9(18):14354-14365 2018 Molecular progression risk score for prediction of muscleinvasion in primary T1 high-grade bladder cancer. CLINICAL GENITOURINARY CANCER 2018;16(4):274-280 2018 CDC6 mRNA Expression Is Associated with theAggressiveness of Prostate Cancer. JOURNAL OF KOREAN MEDICAL SCIENCE 2018;33(47):- 2019 Trends in clinical, operative, and pathologiccharacteristics of surgically treated renal mass in aKorean center: A surgical series from 1988 through2015. INVESTIGATIVE AND CLINICAL UROLOGY 2019;60(3):184-194 2019 Methylation Signature for Prediction of Progression FreeSurvival in Surgically Treated Clear Cell Rena CellCarcinoma. JOURNAL OF KOREAN MEDICAL SCIENCE 2019;34(19):- 2019 Twenty-four-hour urine osmolality as a representativeindex of adequate hydration and a predictor ofrecurrence in patients with urolithiasis. INTERNATIONAL UROLOGY ANDNEPHROLOGY 2019;51(7):1129-1135 2019 ZNF492 and GPR149 methylation patterns as prognosticmarkers for clear cell renal cell carcinoma: Array-basedDNA methylation profiling. ONCOLOGY REPORTS 2019;42(1):453-460 2020 A Low Geriatric Nutritional Risk Index is Associated withAggressive Pathologic Characteristics and Poor Survivalafter Nephrectomy in Clear Renal Cell Carcinoma: AMulticenter Retrospective Study. NUTRITION AND CANCER-ANINTERNATIONAL JOURNAL 2020;72(1):88-97 2020 The age adjusted Charlson comorbidity index as apredictor of overall survival of surgically treated nonmetastatic clear cell renal cell carcinoma. JOURNAL OF CANCER RESEARCH ANDCLINICAL ONCOLOGY 2020;146(1):187-196 2020 A novel urinary mRNA signature using the droplet digitalpolymerase chain reaction platform improvesdiscrimination between prostate cancer and benignprostatic hyperplasia within the prostate-specific antigengray zone. Investigative and Clinical Urology 2020;61(4):411-418 2020 Intraoperative allogeneic blood transfusion is associatedwith adverse oncological outcomes in patients withsurgically treated non-metastatic clear cell renal cellcarcinoma. INTERNATIONAL JOURNAL OF CLINICALONCOLOGY 2020;25(8):1551-1561 2020 Parathyroid hormone is associated with prostate cancer. Prostate International 2020;8(3):116-120 2021 A Molecular Signature Determines the Prognostic andTherapeutic Subtype of Non-Muscle-Invasive BladderCancer Responsive to Intravesical BacillusCalmette-Guerin Therapy. INTERNATIONAL JOURNAL OFMOLECULAR SCIENCES 2021;22(3):- 2021 A high basal metabolic rate is an independent predictorof stone recurrence in obese patients. INVESTIGATIVE AND CLINICAL UROLOGY 2021;62(2):195-200 2021 A high basal metabolic rate is an independent predictorof stone recurrence in obese patients. INVESTIGATIVE AND CLINICAL UROLOGY 2021;62(2):195-200 2021 Urinary microrna-1913 to microrna-3659 expressionratio as a non-invasive diagnostic biomarker for prostatecancer. INVESTIGATIVE AND CLINICAL UROLOGY 2021;62(3):340-348 2021 Effect of pre-operative internal obturator muscle massindex in MRI on biochemical recurrence of prostatecancer patients after radical prostatectomy: amulti-center study. BMC UROLOGY 2021;21(1):- 2021 Expression of phosphorylated p21-activated kinase 4 isassociated with aggressive histologic characteristics andpoor prognosis in patients with surgically treated renalcell carcinoma. INVESTIGATIVE AND CLINICAL UROLOGY 2021;62(4):399-407 2021 The prognostic value of the pretreatment serum albuminto globulin ratio for predicting adverse pathology inpatients undergoing radical prostatectomy for prostatecancer. INVESTIGATIVE AND CLINICAL UROLOGY 2021;62(5):545-552 2021 Nutritional status assessed by the controlling nutritionalstatus (Conut) score as a predictor of recurrence ofurolithiasis. INVESTIGATIVE AND CLINICAL UROLOGY 2021;62(5):553-559 2021 Nutritional status assessed by the Controlling NutritionalStatus (CONUT) score as a predictor of recurrence ofurolithiasis. INVESTIGATIVE AND CLINICAL UROLOGY 2021;62(5):553-559
번호, 진료언론사, 보도명, 보도일자 정보제공
번호 언론사 보도명 보도일자